A detailed history of Tcg Crossover Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 2,890,816 shares of CNTA stock, worth $50.7 Million. This represents 6.0% of its overall portfolio holdings.

Number of Shares
2,890,816
Previous 2,890,816 -0.0%
Holding current value
$50.7 Million
Previous $26.1 Million 77.08%
% of portfolio
6.0%
Previous 3.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $6.83 Million - $10.1 Million
850,000 Added 41.65%
2,890,816 $26.1 Million
Q3 2023

Nov 14, 2023

BUY
$6.01 - $8.24 $12.3 Million - $16.8 Million
2,040,816 New
2,040,816 $13.2 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.65B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.